Newsletter

Cart One Plus, a ring-shaped medical device, received approval from the Ministry of Food and Drug Safety in Korea for its blood pressure measurement function

Skylabs Co, Ltd (CEO Byung-Hwan Lee) announced on the 27th that its ring-shaped wearable device ‘CART-ⅠPlus’ has received permission from the Ministry of Food and Drug Safety in Korea for its blood pressure measurement function.

CartOne Plus boasts excellent convenience by measuring blood pressure using photoplethysmography in an ‘off the cuff’ method, rather than a ‘cuff’ method where blood pressure is measured by compressing the forearm. Being a ring-shaped device, it can be continuously monitored for 24 hours without additional treatment when worn on the finger, and the inconvenience of existing blood pressure measuring devices has been greatly improved.

In particular, it provides variable blood pressure data that has been difficult to accurately determine until now, such as nighttime blood pressure, morning hypertension, and confirmation of blood pressure variability It is effective in tracking changes lifestyle such as management, exercise, drinking, and response to taking blood pressure medication.

Lee Byeong-hwan, CEO of Skylabs, said, “Cartone Plus, which has an additional blood pressure measurement function, accelerates the approval of the US FDA and European CE approval following the approval of the Food and Drug Administration.” We will accelerate our global expansion with the aim of changing the lives of patients outside the hospital by expanding the scope of management to include nocturnal hypertension, which has grown significantly in importance.”

In January, Skylabs, selected as an innovative medical device company by the Ministry of Food and Drug Safety, was designated as an innovative medical device company by the Ministry of Food and Drug Safety at the 38th International Hospital Equipment and Medical Equipment Exhibition (KIMES)’ held at COEX in Samseong-dong from March 23 to 26. At the medical device booth, CartOne Plus, which has a blood pressure measurement function, was introduced and attracted attention. Cartwon Plus was recognized as an intermittent electrocardiogram behavioral treatment benefit by the Health Insurance Review and Assessment Service in June of last year, and is currently being sold to general consumers under a copyright contract with Chong Kun Dang, and is intended to provide a product new too. be released soon.

Copyright ⓒ Acrofan All Rights Reserved.